Home>
Stocks>
Alpa Laboratories Ltd

Alpa Laboratories Ltd (ALPA)

₹89.75▲0.56%

Get free price alerts. Set up your Free investment account to get Live Prices. >

Overview

Fundamentals

Q3 '23 Results

Technicals

News and Events

Alpa Laboratories Ltd share Performance

₹86.85
₹91.3
₹89.75
3.23%
Low
Day's Volatility:4.96%
High
1.73%
₹55
₹115
₹89.75
38.72%
Low
52 Weeks Volatility:66.85%
High
28.13%

Returns %
1 Month Return	-0.5 %
3 Month Return	-13.35 %
1 Year Return	+ 53.22 %

Market Stats
Previous Close	₹₹89.25
Open	₹₹91.30
Volume	₹17.31K
Upper Circuit	₹-
Lower Circuit	₹-
Market Cap	₹₹187.78Cr

Company Information

M/s Alpa Laboratories, established in 1967, was incorporated as a private limited company in 1988 and was converted to a public limited company in 1998. Their products include ethical drugs, generic drugs, OTC, and veterinary products in various dosage forms under the trade mark Alpa, which is a registered trademark owned by a promoter group company. They have also manufactured formulations for national and international companies such as Cipla and Zydus Cadila, and supplied contract manufacturing services in countries such as Liberia and Nigeria. The established product-marketing network covers both metro and mini metro cities, and business is categorized into Branded Generic Division, Veterinary Division, Exports Division and Contract Manufacturing Division. The company commenced commercial production at their new Rau (Indore District, Madhya Pradesh) unit in 1999.

Share Price: ₹89.75 per share as on 18 May, 2024 04:01 PM
Market Capitalisation: ₹187.78Cr as of today
Revenue: ₹27.31Cr as on December 2023 (Q4 23)
Net Profit: ₹4.51Cr as on December 2023 (Q4 23)
Listing date: 06 Aug, 2007
Chairperson Name: Mahendra Singh Chawla

Organisation	Alpa Laboratories Ltd
Headquarters	Indore
Industry	Pharmaceuticals
E-voting on shares	Click here to vote

Key events for Alpa Laboratories Ltd

Alpa Laboratories Ltd's Key Financial Indicators Look Decent Despite Share Price Drop - 04 Apr, 2024
Despite a 14% drop in share price over the past three months, Alpa Laboratories' key financial indicators look decent. Markets usually reward more resilient long-term fundamentals, which could mean that the stock may potentially rise in the future.

Fundamentals of Alpa Laboratories Ltd

Insights on Alpa Laboratories Ltd

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

POSITIVE IMPACT
Retail Holding Up
Retail Investor have increased holdings from 41.75% to 42.20% in Mar 2024 quarter
NO EFFECT
Promoter Holding Unchanged
Promoters holdings remained unchanged at 57.29% of holdings in Mar 2024 quarter
NO EFFECT
Against Peers
In the last 3 years, Sun Pharmaceuticals Industries Ltd has given 121.7% return, outperforming this stock by 64.6%
NO EFFECT
Against Peers
In the last 1 year, Zydus Lifesciences Ltd has given 107.0% return, outperforming this stock by 53.7%
NEGATIVE IMPACT
Price Dip
In the last 3 months, ALPA stock has moved down by -13.4%
NEGATIVE IMPACT
FII Holding Down
Foreign Institutions have decreased holdings from 0.95% to 0.50% in Mar 2024 quarter
NEGATIVE IMPACT
Profit Down
Netprofit is down for the last 2 quarters, 5.79 Cr → 4.51 Cr (in ₹), with an average decrease of 22.1% per quarter
NEGATIVE IMPACT
Revenue Fall
Revenue is down for the last 2 quarters, 35.35 Cr → 30.86 Cr (in ₹), with an average decrease of 12.7% per quarter